Hsieh, Ching-Reigh
Wu, Ren-Chin
Kuo, Chia-Jung
Yeh, Pai-Jui
Yeh, Yuan-Ming
Chen, Chyi-Liang
Chiu, Cheng-Tang
Chiu, Cheng-Hsun
Pan, Yu-Bin
Tsou, Yung-Kuan
Le, Puo-Hsien
Article History
Received: 31 December 2023
Accepted: 12 April 2024
First Online: 26 April 2024
Declarations
:
: The study protocol was approved by the Institutional Review Board of the Chang Gung Medical Foundation (approval document No. 202101234B0. “Clinical presentations and outcomes of cytomegalovirus, herpes simplex virus, Epstein-Barr virus, and Clostridioides difficile”) from July 28, 2021 to July 27, 2022. The Institutional Review Board waived informed consent from individual patients to review medical records from the electronic medical record system, in retrospective studies. The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki, as reflected in a prior approval by the institution’s human research committee.
: Not applicable.
: The authors declare no competing interests.